Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile disease

• Main Authors: Boone, James Hunter, Carman, Robert J, Wilkins, Tracy D, Lyerly, David M
• Format: Patent
• Language: English
• Published: 21.05.2019
• Subjects: HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEDICAL OR VETERINARY SCIENCE; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; TESTING

Clostridium difficile disease involves a range of clinical presentations ranging from mild to self-limiting diarrhea to life-threatening pseudomembranous colitis and megacolon. Cases of C. difficile are treated differently depending on severity of disease. Mild and moderate cases may be treated with...